1.17
Finanzdaten der Decoy Therapeutics Inc-Aktie (DCOY)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
0.2276
|
- | - | - | - |
| Operating Expenses |
15.21%
2.631
|
2.2837 | 9.0346 | 0.8951 | 0.9656 |
| Operating Income/Loss |
15.21%
-2.631
|
-2.2837 | -9.0346 | -0.8951 | -0.9656 |
| Net Income/Loss |
6.71%
-2.3738
|
-2.2246 | -8.9777 | -0.8735 | -0.9578 |
| Basic Average Shares |
0.00%
0.532
|
0.532 | - | 0.4816 | 2.1229 |
| Diluted Average Shares |
0.00%
0.532
|
0.532 | - | 0.4816 | 2.1229 |
| Basic Earnings Per Share |
6.70%
-4.46
|
-4.18 | - | -1.81 | -0.45 |
| Diluted Earnings Per Share |
6.70%
-4.46
|
-4.18 | - | -1.81 | -0.45 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):